Pediatric flu vaccine data
Influenza strain data and vaccine response research for pediatric populations "has not really gotten the priority...it deserves" due to limited resources, Office of Vaccines Research & Review Supervisory Medical Officer Roland Levandowski, MD, tells agency's vaccines advisory committee. In January 2002, committee "strongly recommended" that strain surveillance data be obtained from a pediatric population to study immunogenicity and efficacy of the vaccine. At Feb. 20 meeting on strain selection, several committee members cited a pressing need for pediatric data in light of recommendations for increased flu vaccine use in children (1"The Pink Sheet" July 8, 2002, p. 12)...
You may also be interested in...
A pediatric flu vaccine containing two influenza B strains should be developed, members of the FDA's Vaccines & Related Biological Products Advisory Committee recommended
Expanding influenza vaccination recommendations to include infants between six and 23 months and children who are household contacts of high-risk groups could increase costs to the public sector by $59.6 mil. annually
Hanmi showcases at JPM its contract production capabilities for COVID-19 vaccines as South Korea prepares to bring in candidates from several global developers, while LG Chem highlights progress across multiple pipeline projects.